🌟 Transforming Duchenne Muscular Dystrophy Care 🌟
Children's Health℠ and UT Southwestern are pioneering research to revolutionize Duchenne Muscular Dystrophy (DMD) care. They're exploring four critical medication classes:
1️⃣ **Exon-Skipping Therapies:** These RNA-based treatments slow the progression of DMD, improving patients' lives.
2️⃣ **Gene Replacement Therapy:** A groundbreaking approach aims to replace the entire defective DMD gene, potentially stopping disease progression.
3️⃣ **Steroid Alternatives:** Vamorolone offers anti-inflammatory benefits with fewer side effects, providing a promising alternative to corticosteroids.
4️⃣ **Cardiac-Derived Cell Therapy:** CAP-1002 may encourage muscle cell regeneration and decrease inflammation.
Children's Health is committed to advancing DMD research and providing the best care. #DMDResearch #medicaladvancements #NurseRecruitment #NurseHiring #NursingOpportunities #NurseJobs #nurse #nurselife #NursingCareer #nurseIO
Duchenne muscular dystrophy (DMD) is a condition that causes gradual skeletal and heart muscle degeneration which worsens with time. In collaboration with UT Southwestern Medical Center, our neurologists are researching innovative DMD treatments to improve symptoms, quality of life and life expectancy for children. Learn more about our innovative treatments for patients with DMD: https://bit.ly/494MmDI
Innovative therapies for Duchenne muscular dystrophy – Children's Health
Registered Nurse, Certified Clinical Research Nurse, Lead
1moSo proud of the neuromuscular team. Love you guys.